Manchester Triage System-Based Digital Decision Support System and Nurse Triage Accuracy (MTS-DSS)

September 18, 2026 updated by: Zalihe Sarı Amca, Kibrıs Aydin Üniversitesi

Effect of a Manchester Triage System-Based Digital Decision Support System on Nurse Triage Accuracy and Triage Concordance

This study aims to evaluate the effect of a Manchester Triage System-based digital decision support system on emergency nurses' triage accuracy and agreement. Triage is the process of assessing patients when they arrive at the emergency department and determining how urgently they need care. In this study, emergency nurses will first perform routine triage without using the digital system. They will then receive training on the Manchester Triage System and the use of the digital decision support system. In the following phase, nurses will perform triage using their usual clinical assessment and the digital system. The study will compare nurses' triage decisions before and after the intervention and examine the agreement between nurses' decisions and the digital system. The study will be conducted in the adult emergency department of Dr. Burhan Nalbantoğlu State Hospital in Nicosia, Northern Cyprus. The findings may help determine whether a digital decision support system can improve the consistency and accuracy of emergency triage decisions.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This study will evaluate the effect of a Manchester Triage System (MTS)-based digital decision support system (MTS-DSS) on emergency nurses' triage accuracy and triage concordance. The study will use a single-group pretest-posttest quasi-experimental design and will be conducted in the adult emergency department of Dr. Burhan Nalbantoğlu State Hospital, Nicosia, Northern Cyprus.

Emergency nurses participating in the study will first perform routine triage according to their usual clinical practice during the pretest phase. Patient-related triage information, including presenting complaint and relevant clinical findings, will be recorded by the researcher. The nurses will subsequently receive structured training on the Manchester Triage System and the use of the digital decision support system.

Following the training period, nurses will perform triage during the posttest phase. The nurse will initially make a triage decision based on clinical assessment and will then enter the relevant patient information into the MTS-DSS. The system will provide a triage category based on the MTS algorithms. The nurse may retain or change the initial triage decision after viewing the system output.

The primary evaluations will compare triage accuracy before and after the intervention and assess the concordance between nurses' triage decisions and the MTS-DSS output. Nurse-related characteristics and relevant patient characteristics will also be recorded to describe the study population and examine factors associated with triage decisions.

The digital decision support system is web-based and will be accessed through password-protected accounts. The system will not be integrated with the hospital information system. Patient information will be recorded using study-specific codes rather than directly identifying information. Participation of nurses will be voluntary.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
16

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.
  • Name: Zalihe Sarı Amca, Specialist Nurse
  • Phone Number: +90 +905338619561
  • Email: zalihesari@gmail.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

22 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria for Nurses Being a nurse actively working in the triage area of the emergency department. Voluntarily agreeing to participate in the study. Agreeing to participate in the training program. Inclusion Criteria for Patients Patients aged 18 years and older. Exclusion Criteria for Nurses Being on leave or sick leave during the data collection period. Not participating in the training program. Providing incomplete data. Exclusion Criteria for Patients Patients under 18 years of age.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: MTS-DSS Intervention Group

Emergency nurses will receive structured education on the Manchester Triage System (MTS) and training on the use of the MTS-based digital decision support system. During the posttest phase, nurses will first perform triage based on their clinical assessment and then enter the relevant patient information into the digital decision support system. The system will provide an MTS triage category based on the relevant MTS algorithms. Nurses will be able to retain or change their initial triage decision after reviewing the system output. Triage accuracy and concordance will be assessed before and after the intervention.
Behavioral: Manchester Triage System-Based Digital Decision Support System

The intervention consists of structured Manchester Triage System (MTS) education followed by the use of a web-based MTS-based digital decision support system. Emergency nurses will receive training on the principles, triage categories, algorithms, and discriminators of the MTS, as well as on the use of the digital system. During the posttest phase, nurses will first perform triage based on their clinical assessment and then enter the relevant patient information into the digital decision support system. The system will generate an MTS triage category based on the applicable MTS algorithm. The intervention is designed to support nurses' triage decision-making and improve triage accuracy and concordance.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Triage Accuracy of Emergency Nurses
Time Frame: Participants will be evaluated in 3 stages: Stage 1, 4-week pre-intervention assessment; Stage 2, 17-day MTS training and clinical adaptation; Stage 3, 4-week post-intervention assessment.

The accuracy of emergency nurses' triage decisions will be assessed by comparing the nurses' assigned triage categories with the reference triage category determined according to the Manchester Triage System (MTS). Triage accuracy will be evaluated during the pretest and posttest phases to determine whether the MTS-based digital decision support system improves nurses' triage accuracy.
Participants will be evaluated in 3 stages: Stage 1, 4-week pre-intervention assessment; Stage 2, 17-day MTS training and clinical adaptation; Stage 3, 4-week post-intervention assessment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Kibrıs Aydin Üniversitesi

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Funda Karaman, Assoc Prof, Kıbrıs Aydın University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
November 1, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
April 28, 2027

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
April 30, 2027

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
September 9, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 18, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
September 22, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
September 22, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 18, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
September 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • MTS-DSS-2026-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant-level data will not be shared with other researchers because the data are collected for the specific purposes of this study and will be stored securely in coded form. Data sharing is not planned beyond the research team.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings